Nat Commun 8:15201
Winter J, Jung S, Keller S, Gregory RI, Diederichs S
In the ATTAIN-2 trial including those with T2D and HbA1c of 710%, at week 72, weight loss reached 5.1%, 7%, 9.6% and HbA1c decreased by 1.22%, 1.50%, 1.66% with orforglipron 6 mg, 12 mg, 36 mg, compared to 2% and 0.47% with placebo, respectively [62]
You should be consulted in detail in order to evaluate your eligibility and to check your safety during the treatment course
Avoid high-fat, greasy, and heavily seasoned foods during the first few weeks at each new dose level
At Gard Wellness Solutions in Boynton Beach, Florida, our experienced team is dedicated to providing personalized care and support to help you achieve your health goals